Techniques for detecting chromosomal aberrations in myelodysplastic syndromes

Qibin Song1, Min Peng1, Yuxin Chu1

  • 1Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.

Oncotarget
|October 6, 2017
PubMed
Summary

Myelodysplastic syndromes (MDS) involve chromosomal abnormalities crucial for disease progression. Detecting these genetic changes aids in MDS categorization, risk assessment, and treatment decisions.